Skip to main content
Industry News
Study: African American, older adults less likely to get PERT

African American and older patients with pancreatic cancer are less likely to receive pancreatic enzyme replacement therapy, which may help prevent malnutrition, morbidity and mortality, according to a study led by C. Roberto Simons-Linares, MD, MSc of Cleveland Clinic and presented at ACG's 2020 Annual Virtual Scientific Meeting. PERT was prescribed more often in patients with chronic pancreatitis, malnutrition, bariatric surgery and vitamin D deficiency.

Full Story: